Go to the list of all blogs
Anna G's Avatar
published in Blogs
Oct 05, 2023
Life/Health Insurance Plunge: Dive -2.99%! $CNO, $UNM, $AFL, $AEL, $MFC and More!

Life/Health Insurance Plunge: Dive -2.99%! $CNO, $UNM, $AFL, $AEL, $MFC and More!

Life/Health Insurance Stocks Experience a 2.99% Decline!

📉 Intro Description:
Life/Health insurance stocks are under pressure, seeing a loss of nearly 3%. With a "Strong Sell" rating backing most stocks in this category, traders need to exercise caution. A deeper dive will provide a better understanding of individual stocks and market movements.

📉 Life/Health Insurance Sector Faces Challenges with a -2.99% Loss, but AI Robots Can Help You Minimize Losses! 🤖📈

With AI-powered tools at your disposal, you can better navigate the Life/Health Insurance sector, mitigate potential losses, and make data-driven choices.

📊 "Swing Trader, Long Only: Valuation & Efficiency Model (TA&FA)" offers a strategic approach to valuation and efficiency within the sector. By leveraging AI insights, you can make more informed decisions and optimize your trading within this space.

🌟 "Swing Trader, Long Only: Valuation & Seasonality Model (TA&FA)" takes into account seasonality trends, allowing you to adjust your strategy based on historical patterns.

Stay ahead of market fluctuations with AI precision! 💼📊🌟

Tickers of this Group:
$CNO $UNM $AFL $AEL $MFC $PRU $MET $GNW $PUK $LNC $PRI $NWLI $BHF $FG $GL $ABL $BHFAN $BHFAO $BHFAP $JXN $BHFAM

🏢 Industry Description:

Life insurance companies offer policies that pay beneficiaries a lump sum upon the insured's death. These policies can be term or whole life. Life insurance firms might also provide long-term disability policies to replace income if the insured becomes sick or disabled. Health insurance helps cover medical expenses. Major players include Anthem, Inc., MetLife, Inc., and Aflac Incorporated.

📊 Market Cap:
The average market cap across this industry is 14.1B. Topping the list is $MET with a valuation of 46.4B, while $BHFAN stands at the lower end with zero.

📈 High and Low Price Notable News:
Price growth in the last week was -3.31% on average across all stocks in the sector. Monthly and quarterly price growth rates stand at -5.83% and 10.96% respectively. $ABL stands out with a positive growth of 2.36%, while $BHFAM declined the most, dropping 7.86%.

  • News Flashes:
    • $MET: Fell by 5.17% this week.
    • $LNC: Dropped by a staggering 9.54% this week.
    • $MFC: Experienced a decline of 5.56% this week.

🔊 Volume:
Weekly volume growth averaged 8.92% across all stocks. Monthly and quarterly volume growth rates for the same set of stocks were 65.33% and 21.24% respectively.

  • Volume Highlights:
    • $CNO: Saw a record-breaking growth of 112% of the 65-Day Volume Moving Average.
    • $AEL: Experienced a record-breaking daily growth of 300% of the 65-Day Volume Moving Average.
    • $BHF: Recorded a record-breaking daily growth of 223% of the 65-Day Volume Moving Average.

📚 Fundamental Analysis Ratings:

  • Valuation Rating: 53
  • P/E Growth Rating: 42
  • Price Growth Rating: 46
  • SMR Rating: 95
  • Profit Risk Rating: 69
  • Seasonality Score: 46

🌐 Notable Companies:
Prominent companies in this industry include MetLife ($MET), Prudential Financial ($PRU), Lincoln National Corp ($LNC), and Genworth Financial ($GNW).

📜 Ticker Analysis:

$CNO:

MACD Analysis: Turned negative on October 03, 2023, indicating a potential decline with a probability of 71%.

Stock Forecast: Price of $23.05 is trading between resistance of $24.64 and support of $21.07. Price fell by 2% in the last month.

$UNM:

Moving Average Analysis: Fell below its 50-day Moving Average on October 03, 2023. A downward trend is probable with 76% chances.

Stock Forecast: Current price of $48.15 is trading between support of $48.26 and resistance of $40.99. Price declined by 2% over the last month.
 

$AFL:

Momentum Indicator Analysis: Moved below the 0 level on October 02, 2023, signaling a probable shift to a new downward trend. The historical trend shows a 56% chance of a further decline.

Stock Forecast: The current price of $76.07 has surpassed the resistance line at $64.00 and is trading between support at $97.03 and resistance at $64.00. Over the last month, the price showed a +1% Uptrend, but declined by 1% in the past week.

$AEL:

Momentum Indicator Analysis: The indicator moved below the 0 level on September 25, 2023. This suggests a potential downward trend. Historically, in similar scenarios, the stock declined 68% of the time.

Stock Forecast: Currently trading at $53.40, the stock has crossed its resistance of $50.98. It's now positioned between the $58.39 resistance and $50.98 resistance lines. The past month witnessed a slight downtrend of -0.95%, with the stock falling -0.90% in the last week.

$MFC:

Moving Average Analysis: The 50-day Moving Average for MFC crossed below its 200-day moving average on September 29, 2023. This is typically seen as a long-term bearish signal.

Stock Forecast: The current stock price of $17.68 is trading between support at $17.93 and resistance at $14.80. In the last month, there has been a -5% downtrend, and in the past week, the stock has declined by 5%.

$PRU:

Trend Analysis: PRU is in a 3.74% downward trend, witnessing decline for three consecutive days as of October 03, 2023. Historically, 65% of similar situations led to further declines in the following month.

Stock Forecast: PRU, priced at $91.17, has crossed its support line at $88.99. It currently trades between the resistance at $123.23 and support at $88.99. Over the last month, a -4% downtrend was observed, with a 4% decline in the last week.

$MET:

Moving Average Analysis: The stock moved below its 50-day Moving Average on September 27, 2023, suggesting a shift from an upward trend to a downward one. There's a 59% likelihood of the stock continuing this downward trend based on past data.

Stock Forecast: With a current price of $59.99, it is below the lowest support line of $65.15 defined by A.I. The past month saw a -5% decline, with a weekly decline of -4%.

$GNW:

Moving Average Analysis: As of October 03, 2023, GNW moved below its 50-day Moving Average, indicating a potential change from an upward trend to a downward one. Historically, the stock has decreased 85% of the time in such scenarios.

Stock Forecast: Trading at $5.88, the stock has crossed its support at $5.27. It's now between the support of $6.88 and $5.27. The past month witnessed a -2% decline, with a similar -2% decrease in the past week.

 

Related Ticker: CNO, UNM, AFL, AEL, MFC, PRU, MET, GNW, PUK, LNC, PRI, NWLI, BHF, FG, GL, ABL, BHFAN, BHFAO, BHFAP, JXN, BHFAM

CNO's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for CNO moved out of overbought territory on August 07, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 instances where the indicator moved out of the overbought zone. In of the 41 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNO as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CNO turned negative on August 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .

CNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 292 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.911) is normal, around the industry mean (1.401). P/E Ratio (18.455) is within average values for comparable stocks, (20.657). CNO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.271). Dividend Yield (0.013) settles around the average of (0.046) among similar stocks. P/S Ratio (1.114) is also within normal values, averaging (1.312).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are MetLife (NYSE:MET), Prudential Financial (NYSE:PRU), Lincoln National Corp (NYSE:LNC), Genworth Financial (NYSE:GNW).

Industry description

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

Market Cap

The average market capitalization across the Life/Health Insurance Industry is 18.58B. The market cap for tickers in the group ranges from 228.36K to 154.94B. PIAIF holds the highest valuation in this group at 154.94B. The lowest valued company is GWGHQ at 228.36K.

High and low price notable news

The average weekly price growth across all stocks in the Life/Health Insurance Industry was -4%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -0%. ABX experienced the highest price growth at 4%, while FG experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Life/Health Insurance Industry was 85%. For the same stocks of the Industry, the average monthly volume growth was 41% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 73
Price Growth Rating: 57
SMR Rating: 83
Profit Risk Rating: 63
Seasonality Score: -10 (-100 ... +100)
View a ticker or compare two or three
CNO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of health and life insurance services

Industry LifeHealthInsurance

Profile
Details
Industry
Life Or Health Insurance
Address
11825 N. Pennsylvania Street
Phone
+1 317 817-6100
Employees
3500
Web
https://www.cnoinc.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.